117 related articles for article (PubMed ID: 14667998)
21. Effects of low dose of tibolone on steroid receptors and Bcl-2 on the postmenopausal endometrium.
Reis BF; Lima SM; Silva GM; Francisco AM; Barbosa LC; Archangelo SC; Grande RM
Histol Histopathol; 2016 Jun; 31(6):629-34. PubMed ID: 26670665
[TBL] [Abstract][Full Text] [Related]
22. Oestrogen action in the endometrium and oviduct of rhesus monkeys during RU486 treatment.
Brenner RM; Slayden OD
Hum Reprod; 1994 Jun; 9 Suppl 1():82-97. PubMed ID: 7962475
[TBL] [Abstract][Full Text] [Related]
23. Effects of drospirenone/estradiol on steroid receptors and Bcl-2 in the postmenopausal endometrium.
Lima SM; Reis BF; Yamada SS; Postigo S; Grande RM; Botogoski SR; Campaner AB; Hueb CK; Galvão MA
Climacteric; 2011 Oct; 14(5):551-7. PubMed ID: 21469974
[TBL] [Abstract][Full Text] [Related]
24. The effect of transdermal oestradiol on bleeding pattern, hormonal profiles and sex steroid receptor distribution in the endometrium of Norplant users.
Boonkasemsanti W; Reinprayoon D; Pruksananonda K; Niruttisard S; Triratanachat S; Leepipatpaiboon S; Wannakrairot P
Hum Reprod; 1996 Oct; 11 Suppl 2():115-23. PubMed ID: 8982753
[TBL] [Abstract][Full Text] [Related]
25. Effect of onapristone and medroxyprogesterone acetate on the proliferation and hormone receptor concentration of human breast cancer cells.
Classen S; Possinger K; Pelka-Fleischer R; Wilmanns W
J Steroid Biochem Mol Biol; 1993 Apr; 45(4):315-9. PubMed ID: 8499339
[TBL] [Abstract][Full Text] [Related]
26. Analysis of estrogen- and progesterone-receptor expression in endometrial polyps.
Lopes RG; Baracat EC; de Albuquerque Neto LC; Ramos JF; Yatabe S; Depesr DB; Lippi UG
J Minim Invasive Gynecol; 2007; 14(3):300-3. PubMed ID: 17478359
[TBL] [Abstract][Full Text] [Related]
27. The effects of an antiprogestin, mifepristone, and an antiestrogen, tamoxifen, on endometrial 17 beta-hydroxysteroid dehydrogenase and progestin and estrogen receptors during the luteal phase of the menstrual cycle: an immunohistochemical study.
Mäentausta O; Svalander P; Danielsson KG; Bygdeman M; Vihko R
J Clin Endocrinol Metab; 1993 Oct; 77(4):913-8. PubMed ID: 8408465
[TBL] [Abstract][Full Text] [Related]
28. The effects of tamoxifen on proliferation and steroid receptor expression in postmenopausal endometrium.
Mourits MJ; Ten Hoor KA; van der Zee AG; Willemse PH; de Vries EG; Hollema H
J Clin Pathol; 2002 Jul; 55(7):514-9. PubMed ID: 12101196
[TBL] [Abstract][Full Text] [Related]
29. The early response of the postmenopausal endometrium to tamoxifen: expression of estrogen receptors, progesterone receptors, and Ki-67 antigen.
Tregón ML; Blümel JE; Tarín JJ; Cano A
Menopause; 2003; 10(2):154-9. PubMed ID: 12627041
[TBL] [Abstract][Full Text] [Related]
30. Proliferative activity in postmenopausal endometrium: the lurking potential for giving rise to an endometrial adenocarcinoma.
Sivridis E; Giatromanolaki A
J Clin Pathol; 2004 Aug; 57(8):840-4. PubMed ID: 15280405
[TBL] [Abstract][Full Text] [Related]
31. Regulation of bcl-2 gene family members in human endometrium by antiprogestin administration in vivo.
Critchley HO; Tong S; Cameron ST; Drudy TA; Kelly RW; Baird DT
J Reprod Fertil; 1999 Mar; 115(2):389-95. PubMed ID: 10434946
[TBL] [Abstract][Full Text] [Related]
32. Androgen receptors are acquired by healthy postmenopausal endometrial epithelium and their subsequent loss in endometrial cancer is associated with poor survival.
Kamal AM; Bulmer JN; DeCruze SB; Stringfellow HF; Martin-Hirsch P; Hapangama DK
Br J Cancer; 2016 Mar; 114(6):688-96. PubMed ID: 26930451
[TBL] [Abstract][Full Text] [Related]
33. Effects of selective oestrogen receptor modulators on proliferation in tissue cultures of pre- and postmenopausal human endometrium.
Punyadeera C; Kamps R; Defrère S; Dijcks F; de Goeij A; Ederveen A; Dunselman G; Groothuis P
J Steroid Biochem Mol Biol; 2008 Nov; 112(1-3):102-9. PubMed ID: 18832036
[TBL] [Abstract][Full Text] [Related]
34. Apoptosis, proliferation, and sex steroid receptors in postmenopausal endometrium before and during HRT.
Dahmoun M; Odmark IS; Risberg B; Karlsson MG; Pavlenko T; Bäckström T
Maturitas; 2004 Oct; 49(2):114-23. PubMed ID: 15474755
[TBL] [Abstract][Full Text] [Related]
35. Progestin receptor isoforms and prostaglandin dehydrogenase in the endometrium of women using a levonorgestrel-releasing intrauterine system.
Critchley HO; Wang H; Kelly RW; Gebbie AE; Glasier AF
Hum Reprod; 1998 May; 13(5):1210-7. PubMed ID: 9647549
[TBL] [Abstract][Full Text] [Related]
36. Endometrial and pituitary responses to the steroidal antiprogestin RU 486 in postmenopausal women.
Gravanis A; Schaison G; George M; de Brux J; Satyaswaroop PG; Baulieu EE; Robel P
J Clin Endocrinol Metab; 1985 Jan; 60(1):156-63. PubMed ID: 3964788
[TBL] [Abstract][Full Text] [Related]
37. Differential expression of estrogen and progesterone receptors in endometrial polyps and adjacent endometrium in postmenopausal women.
de Carvalho S; Campaner AB; Lima SM; Silva MA; Ribeiro PA
Anal Quant Cytol Histol; 2011 Apr; 33(2):61-7. PubMed ID: 21980607
[TBL] [Abstract][Full Text] [Related]
38. Progesterone antagonists increase androgen receptor expression in the rhesus macaque and human endometrium.
Slayden OD; Nayak NR; Burton KA; Chwalisz K; Cameron ST; Critchley HO; Baird DT; Brenner RM
J Clin Endocrinol Metab; 2001 Jun; 86(6):2668-79. PubMed ID: 11397870
[TBL] [Abstract][Full Text] [Related]
39. Modification of endometrial cell biology using progesterone antagonists to manipulate the implantation window.
Beier HM; Hegele-Hartung C; Mootz U; Beier-Hellwig K
Hum Reprod; 1994 Jun; 9 Suppl 1():98-115. PubMed ID: 7962476
[TBL] [Abstract][Full Text] [Related]
40. Induction of TGF-beta by an antiprogestin in the human breast cancer cell line T-47D.
Dannecker C; Possinger K; Classen S
Ann Oncol; 1996 Apr; 7(4):391-5. PubMed ID: 8805931
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
